Role of Microbiome in BCG Responsiveness Prediction

Clinical trial NCT05204199 · UNKNOWN

Trial details

NCT number: NCT05204199
Sponsor: Cédric Poyet
Status: UNKNOWN
Study type: OBSERVATIONAL

Microbiome Bladder Cancer

Start date: 2022-02-22
Primary completion: 2025-10-20
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.